Eli Lilly (NYSE:LLY) reported quarterly earnings of $8.38 per share which beat the analyst consensus estimate of $6.01 by 39.43 percent. This is a 32.81 percent increase over earnings of $6.31 per share from the same period last year. The company reported quarterly sales of $22.974 billion which beat the analyst consensus estimate of $20.725 billion by 10.85 percent. This is a 47.67 percent increase over sales of $15.558 billion the same period last year.